This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Hengbin Wang in Ubiquitin E3 Ligase
Introduction
Hengbin Wang is an accomplished inventor based in Hoover, AL (US). He has made significant contributions to the field of biochemistry, particularly in the area of ubiquitin E3 ligase. His work has implications for cancer treatment and protein modulation.
Latest Patents
Hengbin Wang holds a patent for a native or reconstituted complex comprising Bmi1 and/or Ring1 and/or Ring2, which exhibits ubiquitin E3 ligase activity. The patent also includes methods for producing this complex, identifying compounds that modulate its activity, and developing candidate compounds for cancer treatment. Additionally, kits for determining modulation of protein ubiquitination are provided.
Career Highlights
Hengbin Wang is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.
Collaborations
Hengbin Wang collaborates with Yi Zhang, contributing to the advancement of research in ubiquitin E3 ligase and its applications.
Conclusion
Hengbin Wang's contributions to the field of ubiquitin E3 ligase represent a significant step forward in cancer research and treatment. His innovative approaches and collaborative efforts continue to inspire advancements in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile